Tricida, Inc.

NASDAQ
TCDA
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Share chart Tricida, Inc.

About Tricida, Inc.

Фармацевтическая компания Tricida, Inc. сосредоточена на разработке и коммерциализации своего препарата-кандидата TRC101, не абсорбируемого перорального полимера, предназначенного для потенциального лечения метаболического ацидоза у пациентов с хронической болезнью почек (ХБП). Компания завершила фазу 3, двойное слепое плацебо-контролируемое исследование TRC101 у пациентов с ХБП и метаболическим ацидозом. Компания Tricida, Inc. была основана в 2013 году со штаб-квартирой в Южном Сан-Франциско, штат Калифорния.

Main settings

IPO date
2018-06-28
ISIN
US89610F1012
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV -0.006 0
P/E 0 0
Efficiency
Title Value Grade
ROA -102.07 0
ROE 197.1 10
ROIC -68.96 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -1.68 10
Debt/Ratio 2.22 6
Debt/Equity -1.69 10
Growth impulse
Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 20.94 4
Yield EPS, % -50.22 0

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 0.0141 $ 0 $ 0 $ 0 % 0 % 0 %
Week 0.0141 $ 0.0141 $ 0.0141 $ 0 % 0 % 0 %
Month 0.0141 $ 0.0141 $ 0.0141 $ 0 % 0 % 0 %
Three month 0.0141 $ 0.0141 $ 0.0141 $ 0 % 0 % 0 %
Half a year 0.0141 $ 0.0141 $ 0.0141 $ 0 % 0 % 0 %
Year 0.0141 $ 0.0141 $ 0.0141 $ 0 % 0 % 0 %
3 years 12.39 $ 0.0125 $ 13.6 $ -99.89 % 0 % 0 %
5 years 14.18 $ 0.0125 $ 27.22 $ -99.9 % 0 % 0 %
10 years 0 $ 0.0125 $ 43.71 $ 0 % 0 % 0 %
Year to date 0.0141 $ 0.0141 $ 0.0141 $ 0 % 0 % 0 %

Main owners

Institutions Volume Share, %
Orbimed Advisors LLC. 10 280 947 18.47
VR Adviser, LLC 9 050 064 16.26
Blackrock Inc. 3 698 400 6.64
Frazier Life Sciences Management, L.P. 2 549 671 4.58
Commodore Capital, LP 1 975 403 3.55
Vanguard Group, Inc. (The) 1 661 860 2.99
Lion Point Capital, LP 1 367 597 2.46
Baker Brothers Advisors, LLC 1 320 290 2.37
Stonehill Capital Management LLC 1 198 443 2.15
Deep Track Capital, LP 1 177 680 2.12

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Geoffrey M. Parker COO, CFO & Exec. VP 656.28k 1964 (61 year)
Mr. Robert L. McKague J.D. Exec. VP, Company Sec., Gen. Counsel & Chief Compliance Officer 570.51k
Dr. Dawn Parsell Ph.D. Exec. VP of Clinical Devel. 649.17k 1962 (63 years)
Ms. Annie Yoshiyama VP of Fin. & Chief Accounting Officer N/A 1983 (42 years)
Jackie Cossmon VP of Investor Relations & Communications N/A
Mr. Edward J. Hejlek Esq., J.D. Exec. VP of Intellectual Property N/A 1956 (69 years)
Dr. Gerrit Klaerner Ph.D. Founder, Pres, CEO & Exec. Director 992.55k 1972 (53 years)

About company

Address: United States, South San Francisco, 7000 Shoreline Court - Open in google maps, Open in yandex maps
Website: http://www.tricida.com